New Research Uncovers Genetic Switches Linked To Autoimmune Disease In Women

Autoimmune disorders affect women far more often than men, and a major new genetic study of blood cells may help explain why. Researchers in Australia analyzed more than 1.25 million individual immune cells and uncovered over 1,000 genetic switches that behave differently in men and women.

The study, led by scientists at the Garvan Institute of Medical Research, found that many immune-related genes are more active in women. These sex-specific patterns appear to leave female immune systems in a heightened state of readiness, which can be both protective and harmful.

How Sex Shapes Immunity

The research team collected blood samples from 982 healthy adults, including 564 women and 418 men. Using single-cell RNA sequencing, they measured gene activity in peripheral blood mononuclear cells, key immune cells that circulate throughout the bloodstream.

Rather than averaging gene expression across large groups of cells, the scientists analyzed each cell individually. This high-resolution approach revealed clear differences in both the composition and behavior of immune cells between men and women.

Men were found to have higher numbers of monocytes, a type of first-responder immune cell involved in basic repair and maintenance. Women, meanwhile, showed greater numbers of B cells and T cells, which are responsible for adaptive and highly specialized immune responses.

High Alert Brings Higher Risk

In women, B cells and T cells appeared genetically primed to respond rapidly to threats, suggesting a more vigilant immune system overall. This may help explain why women often clear viral infections more efficiently than men and tend to produce stronger responses to vaccines.

However, that same heightened immune reactivity may also increase the risk that immune cells mistakenly attack healthy tissue. This kind of immune misfire is central to autoimmune diseases such as lupus and multiple sclerosis, both of which are significantly more common in women.

Researchers found that genes more active in women were strongly enriched in inflammatory pathways. According to the authors, this provides a biological explanation for the higher burden of autoimmune disease in women beyond previously recognized factors such as hormones and antibody-related differences.

Genetic Switches Across Chromosomes

The study focused on expression quantitative trait loci, or eQTLs, genetic variants that act like switches controlling how strongly certain genes are activated. Many of these sex-biased switches were located not only on the X and Y chromosomes but also on autosomes shared by both sexes.

Two female-biased switches were identified for FCGR3A and ITGB2, genes already associated with systemic lupus erythematosus. This finding supports the theory that subtle inherited differences in gene regulation may create a higher baseline risk for autoimmunity in women.

Overall, the newly mapped sex-specific eQTLs suggest that male immune cells are generally less primed for inflammation. While this may lower autoimmune risk, it could also leave men more vulnerable to severe infections and certain non-reproductive cancers, highlighting a different set of biological trade-offs.

Implications For Precision Medicine

Current treatments for autoimmune diseases such as lupus are still largely one-size-fits-all, typically aiming to broadly suppress inflammation. The new findings point toward a future in which therapies could be tailored not only to the disease itself but also to the patient’s underlying immune biology.

By understanding how male and female immune systems differ at a genetic level, clinicians may eventually be able to develop sex-specific drug regimens or dosing strategies. Such approaches could improve treatment effectiveness while reducing side effects in both women and men.

The study, published in The American Journal of Human Genetics, adds to growing evidence that biological sex is a critical variable in medical research. Experts say incorporating these differences from the earliest stages of research onward will be essential for advancing precision medicine.